InvestorsHub Logo
Followers 43
Posts 5486
Boards Moderated 0
Alias Born 11/15/2013

Re: DOLPHY post# 9964

Thursday, 07/30/2015 9:56:17 PM

Thursday, July 30, 2015 9:56:17 PM

Post# of 466124
This stock has legs to run. Preliminary showed cognizant benefit from taking A-273. No reason why second set of test patients wouldn't receive same benefit as the first set. Next waiting on top line data outcome in September. First set of patients requested to stay on the medication. Take that as a great validation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News